Cargando…
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824534/ https://www.ncbi.nlm.nih.gov/pubmed/35156061 http://dx.doi.org/10.1016/S2665-9913(22)00009-1 |
| _version_ | 1784647034669629440 |
|---|---|
| author | Boekel, Laura Hooijberg, Femke Besten, Yaëlle R Vogelzang, Erik H Steenhuis, Maurice Leeuw, Maureen Atiqi, Sadaf van Vollenhoven, Ronald Lems, Willem F Bos, Wouter H Wijbrandts, Carla A Gerritsen, Martijn Krieckaert, Charlotte Voskuyl, Alexandre E van der Horst-Bruinsma, Irene E Tas, Sander W Boers, Maarten Rispens, Theo Nurmohamed, Michael T Wolbink, Gertjan |
| author_facet | Boekel, Laura Hooijberg, Femke Besten, Yaëlle R Vogelzang, Erik H Steenhuis, Maurice Leeuw, Maureen Atiqi, Sadaf van Vollenhoven, Ronald Lems, Willem F Bos, Wouter H Wijbrandts, Carla A Gerritsen, Martijn Krieckaert, Charlotte Voskuyl, Alexandre E van der Horst-Bruinsma, Irene E Tas, Sander W Boers, Maarten Rispens, Theo Nurmohamed, Michael T Wolbink, Gertjan |
| author_sort | Boekel, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8824534 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88245342022-02-09 COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases Boekel, Laura Hooijberg, Femke Besten, Yaëlle R Vogelzang, Erik H Steenhuis, Maurice Leeuw, Maureen Atiqi, Sadaf van Vollenhoven, Ronald Lems, Willem F Bos, Wouter H Wijbrandts, Carla A Gerritsen, Martijn Krieckaert, Charlotte Voskuyl, Alexandre E van der Horst-Bruinsma, Irene E Tas, Sander W Boers, Maarten Rispens, Theo Nurmohamed, Michael T Wolbink, Gertjan Lancet Rheumatol Comment Published by Elsevier Ltd. 2022-05 2022-02-08 /pmc/articles/PMC8824534/ /pubmed/35156061 http://dx.doi.org/10.1016/S2665-9913(22)00009-1 Text en © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Boekel, Laura Hooijberg, Femke Besten, Yaëlle R Vogelzang, Erik H Steenhuis, Maurice Leeuw, Maureen Atiqi, Sadaf van Vollenhoven, Ronald Lems, Willem F Bos, Wouter H Wijbrandts, Carla A Gerritsen, Martijn Krieckaert, Charlotte Voskuyl, Alexandre E van der Horst-Bruinsma, Irene E Tas, Sander W Boers, Maarten Rispens, Theo Nurmohamed, Michael T Wolbink, Gertjan COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases |
| title | COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases |
| title_full | COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases |
| title_fullStr | COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases |
| title_full_unstemmed | COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases |
| title_short | COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases |
| title_sort | covid-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824534/ https://www.ncbi.nlm.nih.gov/pubmed/35156061 http://dx.doi.org/10.1016/S2665-9913(22)00009-1 |
| work_keys_str_mv | AT boekellaura covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT hooijbergfemke covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT bestenyaeller covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT vogelzangerikh covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT steenhuismaurice covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT leeuwmaureen covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT atiqisadaf covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT vanvollenhovenronald covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT lemswillemf covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT boswouterh covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT wijbrandtscarlaa covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT gerritsenmartijn covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT krieckaertcharlotte covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT voskuylalexandree covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT vanderhorstbruinsmairenee covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT tassanderw covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT boersmaarten covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT rispenstheo covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT nurmohamedmichaelt covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases AT wolbinkgertjan covid19vaccineacceptanceovertimeinpatientswithimmunemediatedinflammatoryrheumaticdiseases |